Angle Share News (AGL)

Angle Information

Buy AGL Shares
Add AGL to Watchlist
Add AGL to Alert

Share Price Information for Angle (AGL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 15.00

Bid: 14.50

Ask: 15.50

Change: 0.00 (0.00%)

Spread: 1.00 (6.897%)

Open: 15.25

High: 15.25

Low: 14.75

Prev. Close: 15.00

Last checked at -

IN BRIEF: Angle to raise GBP20 million through shares placing

Thu, 24th Jun 2021 19:30

Angle PLC - Guildford, England-based liquid biopsy company - Launches a placing to raise gross proceeds of up to GBP20 million at a price of 116 pence each. The company says it will issue 17.2 million shares at a price which represents a discount of 6.8% to the closing mid-market price of its shares of 124.50p on Wednesday. finnCap and WG Partners are acting as joint brokers to the company alongside Beech Hill Securities, which is acting as US broker to the company. Angle says it intends to use the proceeds of the placing to progress commercialisation of the Parsortix system.

Current stock price: 125.00p

Year-to-date change: more than doubled from 47.75p on December 31

By Evelina Grecenko; evelinagrecenko@alliancenews.com

More News

13 May 2013 14:34

Angle shares jump on cell harvesting update

Shares in Angle, a specialist medtech company, leapt 20 per cent on Monday after the group said it has extended the operational capability of its Parsortix non-invasive cancer diagnostic product by automating its cell harvesting function. Harvesting is where captured tumour cells are recovered from

28 Feb 2013 13:36

Angle initiates launch of cancer diagnostic product for market research

Angle, an AIM-listed specialist medtech company, has initiated the launch of its Parsortix non-invasive cancer diagnostic product for the research market. The product is based on taking a blood test, and the system either counts circulating tumour cells (CTCs) in the blood or captures and recovers

31 Jan 2013 13:13

Angle raises funds with placing

Angle, a specialist medtech company, has placed 4.53m new ordinary shares at 50p each, representing a discount of 17.4 per cent on the mid-price of 60.50p per share at close of business on Wednesday. Net of costs, the placing raised £2.2m, which will be used to strengthen the company's financial p

15 Jan 2013 08:47

Angle jumps again after pay out

Medical technology firm Angle saw its shares jump for a second day in a row after it received cash due from the sale of its portfolio company Acoylte Biomedica. The 2007 sale led to a legal case over an earn-out provision, which saw former Acolyte shareholder, Porton Capital, take the buyer, 3M, to

14 Jan 2013 09:46

Angle gains on breakthrough in cancer diagnostic technology

Angle advanced more than 90 per cent Monday after the medtech company announced a major breakthrough in its cancer diagnostic product Parsotix. The AIM listed company said it had edged further in the development of Parsortix, a non-invasive technology which captures and counts rare circulating tu

10 Dec 2012 15:01

Sharp drop in Angle shares following business update

AIM-listed medtech company Angle revealed that Origio, a partner involved in the development of a technology patented as EmbryoSure, has decided to cease EmbryoSure studies in a business update on Monday. EmbryoSure is a technology being developed to assess the viability of embryos for transfer in

7 Jun 2012 13:59

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cya

30 Apr 2012 08:47

Small caps round-up: Westminster Group, Angle, Asterand

Defence technology firm Westminster Group said its investment in a West African airport was looking promising and that an initial aggregate $150m revenue forecast could be achieved by the contract's eight year break point rather than the full contract term of 15 years. "Should that be the case, the

23 Apr 2012 14:31

Small caps round up: Intandem, Digital Learning, Hornby ...

Intandem Films, the London and Los Angeles based international film group, will co-produce 10 Things I Hate About Life, and sell the film internationally. The company will also distribute the film in the UK. The script has been written and the film will be directed by Gil Junger, the director of the

17 Apr 2012 10:40

Angle success with ovarian cancer

Shares in technology investment firm Angle rose on Tuesday after it said its Parsortix cell separation device had passed an important milestone. The firm said that the device could now capture ovarian cancer cells, creating the possibility of developing an effective, non-invasive screening techniqu

11 Apr 2012 09:46

Small caps round-up: Top Level Domain, Transense, SkyePharma

Top Level Domain Holdings, which operates generic top-level domains, has revealed that is wholly-owned subsidiary, Minds and Machines, has been appointed by Dot London Domains (DLD), the official promotional organisation for London, to assist with DLD's application for the position of registry opera

15 Mar 2012 12:06

Small caps round-up: HMV, Corero, ANGLE ...

HMV Group, the struggling entertainment media seller, has confirmed that it is still pondering what to do with its live music business. HMV added that a number of parties have indicated an interest in acquiring the business. There has been press speculation recently about who might be interested in

26 Jan 2012 13:10

Angle raises £1.2m, swings to a half-year loss

Technology investment company ANGLE has raised £1.2m through a fundraising on the same that it revealed it had swung to a loss in the first half ended October 31st. The firm said on Thursday that investors will acquire up to 1,715,717 new ordinary shares in the company at a price of 70p per shar

23 Jan 2012 14:25

Angle makes important step in cancer technology

Angle's 90%-owned portfolio company, Parsortix, which specialises in medical diagnostics, has used its cell separation device to successfully capture circulating tumour cells (CTCs) in cancer patient blood. The Parsortix separation technology has already been used to capture cultured breast cancer

16 Dec 2011 10:37

Angle shares storm north on Parsortix lung cancer result

Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix. Parsortix, which specialises in medical diagnostics, has confirmed its cell separation device can "capture cultured lung cancer cells". This comes af

Latest Share Chat

Angle Share News (AGL)

Share Price Information for Angle (AGL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Angle to raise GBP20 million through shares placing

Login to your account

Quickpicks are a member only feature

Login to your account